Sign in
4

Changes in Ownership

Inhibitor Therapeutics, Inc. Filed Acc 0000899243-20-025807

Options or other derivatives

  • President and CEO acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
VIRCA NICHOLAS J President and CEO 2020-09-17 Grant or award · Common Stock Option +100,000 100,000 D
Loading xslF345X03/doc4.xml…